Global / Top CDMOs 2022
The Contract Development and Manufacturing Organisation (CDMO) industry has boomed in recent years, with Big Pharma increasingly focusing on its core business of R&D and outsourcing other elements of the…
The Siegfried Group is a global life sciences company, headquartered in Switzerland, with facilities located in Switzerland, the USA, Malta, China, Germany and France.
In 2015, the company achieved net sales of CHF 481 million and currently employs approximately 2300 people (FTE). Siegfried Holding AG is publicly listed on the Swiss Stock Exchange in Zurich (SIX: SFZN).
Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Contact
Siegfried AG
Untere Bruehlstrasse 4
CH-4800 Zofingen
Phone: +41 62 746 1111
Fax: +41 62 746 1202
info@siegfried.ch
The Contract Development and Manufacturing Organisation (CDMO) industry has boomed in recent years, with Big Pharma increasingly focusing on its core business of R&D and outsourcing other elements of the…
As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last few decades, while big pharma companies continued to focus on their core business,…
A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from February MAT 2020. Four of the top ten companies are Mexican: PISA,…
Developing manufacturing capacity for as yet unapproved drugs can create huge risk on innovators’ balance sheets, risk which can be mitigated by working instead with a competent CMO – a…
See our Cookie Privacy Policy Here
